Medical Journals

After Dolly--ethical Limits to the Use of Biotechnology on Farm Animals.

Authors:
  • Lassen Jesper
  • Gjerris Mickey
  • Sandøe Peter

From: Centre for Bioethics and Risk Assessment, Royal Veterinary and Agricultural University, Frederiksberg C, Denmark. jlas@kvl.dk

Theriogenology

  • Publish Date: Mar 2006
  • ISSN: 0093-691X
  • Volume: 65
  • Issue: 5
  • Pages: 992-1004
  • Medium: Print
  • Language: English
  • Citation (JAMA): Lassen Jesper, Gjerris Mickey, Sandøe Peter, et al. After Dolly--ethical Limits to the Use of Biotechnology on Farm Animals.. Theriogenology Mar 2006;65:992-1004

Abstract

The cloning of Dolly the sheep gave rise to a widespread call for limits on interference with life. Until recently, the main limits were technical: what it is possible to do. Now scientists are faced with ethical limits as well: what it is acceptable to do. In this context, we take ethics to involve systematic and rational reflection on moral issues raised in the public sphere. The concerns of the general public are not necessarily valid, but they are the best point of departure if the discussion is to lead to a socially robust framework for setting limits to the use of animal biotechnology. To assess public understanding, we examine two sources of data: Eurobarometer surveys from 1991 to 2002 and a qualitative interview study carried out in Denmark in 2000. Based on these sources, we formulate, and then discuss closely, the following concerns: dangers to human health and the environment, animal welfare, animal integrity, and usefulness. In the final part of the article, it is proposed that a principle of proportionality should be the foundation for socially robust applications of animal biotechnology. Only in cases where the usefulness of the technology can be said to outweigh countervailing moral concerns, as in biomedical research, will applications of animal biotechnology stand up to scrutiny in the public sphere.

Mesh Headings (Keywords): Animal Husbandry, Animal Welfare, Animals, Animals, Genetically Modified, Biotechnology, Cloning, Organism, Humans, Public Opinion, Risk Assessment


Check for Full Text / PubMed Unique Identifier (PMID): 16253321


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.